Non-transferable risk: Difference between revisions
From ACT Wiki
Jump to navigationJump to search
imported>Doug Williamson (Create the page. Source: MCT reading 4.1.3, p12, 01 March 2012.) |
imported>Doug Williamson (Link with Committed risk and Uncommitted risk pages) |
||
| Line 9: | Line 9: | ||
== See also == | == See also == | ||
*[[Transferable risk]] | * [[Committed risk]] | ||
* [[Transferable risk]] | |||
* [[Uncommitted risk]] | |||
Revision as of 12:11, 20 May 2015
Non-transferable risks are risks which must be borne by an organisation.
Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.
For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.
